title: Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
authors.affiliation: Rafael Bañares, Unidad de Trasplante Hepático. Servicio de Medicina de Aparato Digestivo. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón. C/ Doctor Esquerdo, 46. 28007 Madrid, Spain. rbanares@telefonica.net.
authors.forename: Ainhoa
authors.initials: A
authors.lastname: Fernández-Yunquera
authors.forename: Diego
authors.initials: D
authors.lastname: Rincón
authors.forename: Magdalena
authors.initials: M
authors.lastname: Salcedo
authors.forename: Rafael
authors.initials: R
authors.lastname: Bañares
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D024882:Drug Resistance, Viral; D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008991:Monitoring, Physiologic; D009842:Oligopeptides / Q000009:adverse effects / Q000627:therapeutic use; D018579:Patient Selection; D011392:Proline / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline